p53 mRNA levels are tightly regulated during the cell cycle with its transcription being induced prior to DNA synthesis. However, the mechanism controlling this regulation is not well defined. Through characterizing an additional 1000 bp of upstream DNA sequences of the murine p53 gene, we identified new positive and negative regulatory elements. Furthermore, we found a trans-acting factor(s) that binds within a positive cis-acting element (À972/À953) in a manner indicative of regulation during the cell cycle. When Swiss3T3 cells are arrested by serum depletion p53 mRNA levels decrease and binding of this regulatory factor(s) to the promoter is reduced. Upon serum stimulation, the regulatory factor(s) binds the promoter and p53 mRNA levels increase prior to the cells entering S phase. When the factors are experimentally sequestered from the promoter or when the regulatory element is deleted from the promoter, p53 promoter activity is reduced. There is no further reduction in p53 promoter activity upon serum depletion and the kinetics of induction upon serum stimulation is delayed by approximately 5 h. These findings indicate that a factor(s) binding within the À972/À953 regulatory element on the p53 promoter is important for the proper regulation of p53 mRNA expression in response to mitogen stimulation. Our initial findings indicate that a member of the C/EBP family of transcription factors may play a role in this regulation.
Introduction
The p53 tumor suppressor gene has been called the 'guardian of the genome' due to its ability to induce several responses within the cell to maintain genomic stability. To maintain the genomic stability of the cell, p53 functions as a sequence-specific transcription factor that regulates the expression of downstream genes required for cell cycle arrest or apoptosis (Vogelstein et al., 2000; Vousden and Lu, 2002) , ultimately preventing damaged DNA from further replication.
Mutations in the p53 gene have been observed in over 50% of all human tumors. Over 85% of the mutations detected in the gene are missense mutations that encode altered forms of the protein which are expressed at elevated levels (Vogelstein et al., 2000; Vousden and Lu, 2002) . Mutant p53 protein not only loses its ability to function as a DNA-damage checkpoint regulator but it can also acquire novel activities that contribute to transformation. For example, when mutant p53 is introduced into nontumorigenic cells that lack endogenous p53 expression the growth rate of the cells increase in culture and the cells become tumorigenic in vivo (Liu et al., 2000; Sigal and Rotter, 2000; Lang et al., 2004; Olive et al., 2004) .
Given that the p53 protein is a critical regulator of cell growth, its expression must be tightly regulated for normal cell division as well as for its ability to function as a tumor suppressor. p53 levels must be suppressed for normal cell division to occur (Choi and Donehower, 1999) , explaining why p53 is found at low levels in normal dividing cells (Kubbutat and Vousden, 1998) . When cells are stressed or damaged, p53 is rapidly induced. Several mechanisms exist to regulate p53 levels and function within the cell.
In normal cells, p53 protein is rapidly degraded after it is synthesized. Regulation of p53 protein levels by degradation is primarily due to the MDM2 protein, a transcriptional target of p53 that functions as an ubiquitin-ligase and mediates ubiquitination of p53, thus targeting it for degradation by the proteasome (Kubbutat et al., 1997; Prives, 1998; Freedman and Levine, 1999) . Therefore, a negative regulatory feedback loop is formed between p53 and MDM2, in which p53 controls expression of its own regulator.
p53 function is also regulated by subcellular localization. As a transcription factor, localization of p53 to the nucleus is essential for its ability to bind and transactivate target genes, such as p21
Wafl/cipl (El-Deiry et al., 1993) and bax (Miyashita and Reed, 1995) , involved in cell cycle arrest and apoptosis. p53 is actively transported into the nucleus by its interaction with microtubules and dynein and through several nuclear localization signals (NLS) within its C-terminus (Giannakakou et al., 2000) . Once in the nucleus, p53 can be exported into the cytoplasm through its two nuclear export signals (NES), one in the N-terminus that is within the MDM2 binding domain and the second in the C-terminus (Stommel et al., 1999; Zhang and Xiong, 2001) , and undergo cytoplasmic proteasome-mediated degradation.
p53 can also be regulated by post-translational modifications, such as acetylation and phosphorylation, which enhance the ability of p53 to bind target genes in a sequence-specific manner and function as a transcription factor once inside the nucleus. For example, in response to stress, acetylation of p53 lysine residues within the C-terminus is a result of histone acetyltransferases, p300/CBP and PCAF (Gu and Roeder, 1997; Liu et al., 1999) . The interaction of histone acetyltransferases with p53 is further enhanced by phosphorylation of serine residues within the N-terminus of p53. Together, these post-translational modifications of p53 result in a phosphorylation/acetylation cascade further enhancing p53 activity (Sakaguchi et al., 1998) . Several studies have also shown that the type of post-translational modification may play a role in determining which downstream pathway is initiated by p53. For example, the apoptotic pathway has been shown to be dependent on phosphorylation of p53 at serine 46, while cell cycle arrest is not dependent on serine 46 phosphorylation (Oda et al., 2000) .
Although most of our knowledge about regulation of p53 function is at the protein level, transcriptional regulation of p53 gene expression during the cell cycle has long been known to occur but has been characterized to a far less extent. In the absence of a DNAdamaging agent, growth-arrested mouse fibroblasts or normal nondividing human B lymphocytes naturally arrested in G 0 have been shown to re-enter the cell cycle by mitogenic stimulation (Reich and Levine, 1984; Reed et al., 1986) . It has been known for some time that p53 mRNA is maintained at low levels during G 0 /G 1 growth arrest and begins to increase with re-entry into the cell cycle in G 1 with peak production before or at the G 1 /S boundary of the cell cycle (Reich and Levine, 1984; Mosner et al., 1995) . The increase in p53 mRNA levels is due to an increase in transcription. On the other hand, the expression of p53 protein lags behind p53 mRNA expression by several hours. The synthesis of p53 protein is low in the G 1 phase of the cell cycle and increases with the onset on DNA synthesis in S phase with peak protein levels in mid-S phase (Reich and Levine, 1984; Mosner et al., 1995) . The increase in p53 protein levels during S phase is due to an increase in protein synthesis. Part of the lag time between p53 mRNA in G 1 and p53 protein expression in S phase could be due to mRNA processing and preparation for translation. Therefore, p53 gene transcription during G 1 would be necessary to allow time for RNA processing so p53 protein is present during DNA synthesis, and if necessary, quickly prevent replication of damaged DNA. Given the importance of p53 expression, transcription of the p53 gene must be tightly regulated during the cell cycle. However, how transcription of the p53 gene is regulated during the cell cycle is not well defined.
In tumor cells, in addition to increased stability of mutant p53 protein (Vogelstein et al., 2000) , mutant forms of p53 mRNA levels are often expressed at higher levels due to increased rates of transcription, as is the case in Burkitt's lymphomas (Balint and Reisman, 1996) . On the other hand, some human tumors do not express detectable levels of p53 mRNA due to reduced transcription of the p53 gene (Stuart et al., 1995; Raman et al., 2000) . In some human breast cancer-derived cells, the p53 gene is found to be structurally intact but not expressed due to the absence of a positive regulator, H0XA5, which normally induces transcription of the p53 gene (Raman et al., 2000) . Therefore, understanding the factors that regulate p53 transcription will provide insight into the relationship between p53 expression during the cell cycle and its deregulation during oncogenic transformation.
The focus of this work is aimed at deciphering how p53 mRNA levels are regulated during the cell cycle in response to mitogen stimulation. In characterizing an additional 1000 bp of upstream DNA sequences, we have identified one positive and two negative regulatory elements. At one element, approximately 960 bp upstream from the transcription start site, we show binding of a trans-acting factor, that appears to be a member of the C/EBP family of transcription factors, to the p53 promoter in a cell cycle regulated manner.
Results

Progression of Swiss 3T3 cells through the cell cycle is regulated by mitogen stimulation
To study the regulation of p53 gene expression during the cell cycle in response to mitogen stimulation, we chose a cell line whose progression through the cell cycle can be regulated via serum treatment. Exponentially growing Swiss3T3 were maintained in serum-depleted medium (medium containing 0.1% fetal bovine serum (FBS)) for 24 h and then serum stimulated (medium containing 15% FBS). Cells were harvested after 24 h serum depletion (0 h) and 3, 8 and every 2 h thereafter, up to 24 h postserum stimulation. The cells shifted into G 0 /G 1 arrest upon 24 h serum depletion as seen in Figure 1a . Serum stimulation resulted in an induction of DNA synthesis, indicated by [ 3 H]thymidine uptake occurring between 8 and l0 h postserum stimulation with maximal levels of DNA synthesis after 16 h ( Figure 1a) . These results were confirmed by flow cytometry which indicated at 3 h postserum stimulation the cells re-enter the cell cycle and at 8 h the cells are at the G 1 /S boundary (data not shown).
Endogenous p53 mRNA levels are cell cycle regulated Based on the results above, we assayed changes in p53 mRNA levels in response to mitogen stimulation. p53 mRNA is maintained at low levels during G 0 /G 1 growth arrest and begin to increase at 3 h postserum stimulation, prior to entry into S phase. The levels of p53 mRNA increase substantially prior to S phase as seen at Figure 1b) . These results are in agreement with earlier publications (Reich and Levine, 1984; Ginsberg et al., 1990; Mosner et al., 1995) . As a control for early response genes, c-myc mRNA levels were also observed to increase at 3 h postserum stimulation ( Figure 1b) . We also assayed the expression of some p53 target genes (p21, mdm2 and 14-3-3s) to determine whether p53 protein was active. We saw no change in the levels of p21 and 14-3-3s mRNA but we did detect an increase in mdm2 mRNA at 18 h post-serum stimulation followed by a decrease at 24 h postserum stimulation. This increase in mdm2 mRNA is in agreement with the work of Mosner et al. (1995) that demonstrated that p53 protein levels increase when the cells are in S phase at 15 h postserum stimulation and decrease at 20 h postserum stimulation. The preferential induction of mdm2 transcription as opposed to p21 and/ or 14-3-3s is also consistent with the findings of Zhao et al. (2000) that demonstrated that p53 responsive genes fall into a number of different classes with respect to their kinetics of induction by p53. The mdm2 gene was found to respond very early to elevated p53 levels while p21 and 14-3-3s responded much later. Furthermore, it was shown that the kinetics of response of any given gene to p53 protein depends on a number of factors including the level of p53 protein in the cell and the cell type in question (Mendrysa and Perry, 2000; Zhao et al., 2000) . Together these results suggest that the rise in p53 protein stimulates the negative regulatory feedback loop between p53 and MDM2 that prevents the accumulation of p53 and activation of additional downstream target genes such as p21 and 14-3-3s ( Figure 1b ) and allows the cells to enter S phase.
Larger p53 promoter fragment has altered activity There are a number of factors known to bind and regulate expression of the p53 promoter however, it is not known which factor or factors are responsible for cell cycle regulation of p53 transcription. Until recently, only a 672 bp cloned murine p53 promoter fragment (0.7 kbp), 332bp of upstream sequences and 340 bp of sequences downstream of the transcription start site, was available for studying promoter activity. This promoter region does not exhibit a cell cycle regulated response (Ginsberg et al., 1990) . In order to search for additional regulatory elements, some of which might be necessary for cell cycle regulated p53 promoter activity, we cloned a larger region of the murine p53 gene consisting of an additional 1000 bp of upstream sequences, which will be referred to as 1.7 kbp (Figure 2a ) (Reisman et al., 2001) . To test for promoter activity, the 1.7 kbp promoter fragment was placed upstream of a luciferase reporter gene and transfected into Swiss3T3 cells. The cells transfected with the 0.7 kbp promoter express three-fold higher basal activity than the 1.7 kbp promoter indicating the presence of one or more negative regulatory elements within the 1000 bp upstream region of the p53 promoter ( Figure 2b ). p53 promoter expression is induced by serum in reporter gene assays It has previously been shown that the 0.7 kbp p53 promoter does not undergo cell cycle regulated transcription (Ginsberg et al., 1990) . Therefore, to test for cell cycle regulated promoter activity, the 1.7 kbp promoter upstream of the luciferase gene was transfected into exponentially growing Swiss3T3 cells. At 18 h after transfection, the cells were maintained in serumdepleted medium for 24 h and then serum stimulated. Cells were harvested after 24 h serum depletion (0 h) and 3, 8, 18 and 24 h postserum stimulation and assayed for luciferase activity. The 1.7 kbp promoter decreased in activity after 24 h of serum depletion with a four-fold reduction in expression ( Figure 2c ). The cells transfected with the 1.7 kbp promoter re-enter the cell cycle at 3 h postserum stimulation and exhibit an induction of promoter activity with maximal promoter activity after Figure 1b ) and indicate that a cis-acting cell cycle regulatory element exists within the 1000 bp upstream region of the murine p53 promoter.
PCR-directed deletion analysis identifies three regulatory regions
To identify regulatory sites within the 1000 bp region of the 1.7 kbp. promoter fragment, PCR-directed deletion analysis was carried out using primers that map progressively toward the 3 0 end of the 1000 bp upstream region of the promoter (Figure 3a ). This generated a series of 120-170 bp deletions that allowed us to identify additional regulatory elements. To test for basal promoter activity, each deletion was transfected and assayed for luciferase activity in exponentially growing Swiss3T3 cells (Figure 3b ). The results identified three regulatory regions (negative within À1572/À1310 bp, positive within À1310/À843 bp and negative within À843/À700 bp) on the p53 promoter ( Figure 3b) .
In order to identify elements involved in cell cycleinduced regulation of p53 promoter activity, Swiss3T3 cells were transfected with each deletion construct (Figure 3a) , serum-depleted for 24 h and then serum stimulated. Cells were harvested at the indicated times post-serum stimulation and assayed for luciferase activity. When transfected into Swiss3T3 cells, deletion constructs 1.572 kbp through 1.019 kbp demonstrated regulation of promoter activity similar to that seen with the 1.7 kbp promoter (Figures 2c and 3c ). Figure 3c shows the response of the 1.310 kbp and 1.019 kbp deletion constructs to serum treatment. These particular deletion constructs are shown as an example since the 1.572, 1.439, 1.310, 1.187 and 1.019 kbp deletion constructs were all regulated in a cell cycle regulated manner similar to the 1.7 kbp promoter. Deleting beyond the endpoint of the 1.019 kbp p53 promoter construct resulted in the loss of the cell cycle regulated promoter activity. The 0.843 kbp and 0.714 kbp p53 deletion constructs, as well as the 0.7 kbp promoter , did not undergo regulated changes in activity in response to serum ( Figure 3c ). While additional cis-active sequences may participate in regulated promoter activity, these results indicate that the region between À1.019 and À0.843 kbp on the p53 promoter is required for proper regulation of promoter activity during the cell cycle.
Mobility shift assays demonstrate protein binding to three regions on the promoter On many promoters, transcription factors are known to bind at distant sites from one another and act synergistically to regulate promoter activity (Carey, 1998) . Therefore, multiple factors may play a role in regulating p53 promoter activity in response to mitogen stimulation. In light of these considerations, electrophoretic mobility shift assays (EMSA) were performed to assay for binding of factors within all three regulatory sites that we have identified on the murine p53 promoter (Figure 3b ). We PCR amplified the three regions and used them to probe nuclear extracts from exponentially growing Swiss3T3 cells. Also, double-stranded 30 bp oligonucleotides that overlap the ends of each of the regions were used to probe nuclear extracts. Binding of a protein, or in some regions, proteins, was observed in each of the three regions (data not shown). We further narrowed down the binding sites within each of the three regions by PCR amplifying smaller pieces and using them as probes in EMSA, always tracking the binding until finally, the sites were narrowed down to four 20 to 30 bp regions (Figure 4a and b) .
To demonstrate that these proteins are binding in a sequence-specific manner and to determine the nucleotides necessary for binding, either two or three base-pair An illustration of the previously cloned 0.7 kbp murine p53 promoter and the newly cloned 1.7 kbp p53 promoter. Some of the known regulatory sites within the 0.7 kbp promoter are shown Wu et al., 1994; Hale and Braithwaite, 1995; Reisman and Loging, 1998; Lasham et al., 2003) . (b) 0.75 and 1.0 mg of either the 0.7 kbp or the 1.7 kbp promoter upstream of the luciferase gene were transfected in duplicate experiments into exponentially growing Swiss3T3 cells. The total amount of DNA was kept at 1.0 mg by the inclusion of empty pGL3-basic luciferase vector. Extracts were prepared after 24 h and assayed for luciferase activity. The results were normalized to TK-Renilla. (c) Exponentially growing Swiss3T3 cells (Exp) were transfected with 1.0 mg of the 1.7 kbp promoter in duplicate. At 18 h after transfection, the cells were maintained in serumdepleted medium for 24 h (0 h) and then serum stimulated. Cells were harvested 3, 8, 18 and 24 h post-serum stimulation and tested for luciferase activity. The results were normalized to TK-Renilla.
Cell cycle regulation of p53 transcription K Boggs and D Reisman changes were made within each binding site. The mutant oligonucleotides were used to probe nuclear extracts from exponentially growing Swiss3T3 cells by EMSA. The loss of binding during EMSA indicated that the altered nucleotides are important for DNA-protein interaction (data not shown). In the region spanning À1325/À1296 and À783/À754 key nucleotides for factors binding the promoter were identified (Figure 4c ). Binding within the À1466/À1447 and the slower migrating product within the À972/À953 region of the promoter was never completely lost when changes were introduced, although, there was a reduction in the intensity of binding when specific nucleotides were changed ( Figure 4c ). However, within the À972/À953 region, binding of the faster migrating product was completely abolished by the mutations that reduced binding of the slower migrating product (Figure 4c ). These results indicate that binding site of the faster migrating product is more stringent than the binding site required of the slower migrating product. Others have noted that an alteration of nucleotides within a binding site may not always abrogate binding of certain factors. It has been suggested that this may be due to a loose consensus sequence, which also may be the case here (McKnight, 2001 ). In addition, two of the sites (À1466/ À1447 and À972/À953; slowest migrating product) demonstrated binding with diffuse bands (Figure 4a ). This could indicate multiple factors binding within the region and may further explain the difficulty in eliminating binding upon mutagenesis of these sites. Factor-binding to the promoter in a cell cycle regulated response To determine which factor(s) may play a role in cell cycle regulation of p53 promoter activity, we examined the binding patterns of these factors on the promoter during the cell cycle. EMSA was performed using nuclear extracts prepared from Swiss3T3 cells that were serum-depleted for 24 h followed by serum stimulation. We tested each of the regions we found to bind factors from serum-treated cells (data not shown) and only one of the regions, À972/À953, bound a factor(s) in a cell cycle regulated manner ( Figure 5 ; slowest migrating product indicated by upper arrow). Upon serum depletion, binding of the factor(s) is significantly reduced; however, upon serum stimulation the factor(s) increases in binding activity. Also, a faster migrating product is constitutively binding within this region ( Figure 5 ; indicated by lower arrow). As is apparent in Figure 5 , binding that occurs in a cell cycle regulated manner gives rise to a diffuse band. As described above, the diffused nature of the band could indicate multiple factors binding or could indicate modification of the bound protein(s).
Deletion of the À972/À953 binding site alters cell cycle regulation of p53 promoter activity Since differential binding of a factor(s) to the À972/ À953 element of the p53 promoter occurred in a cell cycle regulated manner ( Figure 5 ; slowest migrating product), we chose to further explore the role of these factors in regulating p53 promoter activity in response to serum stimulation. As indicated above, we never completely abolished binding of the slower migrating The nucleotides that are in bold are nucleotides that were mutated in pairs. The nucleotides that are underlined are nucleotides that were mutated in groups of three. The dot ( Á ) above nucleotides indicates nucleotides necessary for protein binding by EMSA. The boxed nucleotides are nucleotides that when mutated both in pairs or in groups of three resulted in a complete loss of binding of the fastest migrating product within the À972/À953 region and a reduction in the intensity of binding to the À1466/À1447 and À972/À953 region (slowest migrating product).
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product when we tested mutant oligonucleotides, therefore we deleted the entire À972/À953 binding site from the promoter and assayed activity of this deletion construct during the cell cycle. Exponentially growing Swiss3T3 cells, transfected with the 1.7 kbp promoter À972/À953 deletion construct, were serum-depleted, stimulated and assayed for promoter activity. Serumdepleted and stimulated cells transfected with the wildtype full-length 1.7 kbp promoter exhibit cell cycle regulated activity (Figures 2c and 6a ), while cells transfected with the 1.7 kbp À972/À953 deletion construct exhibit a very different pattern of activity ( Figure 6b ). In comparison to the wild-type full-length 1.7 kbp promoter, the 1.7 kbp À972/À953 deletion construct is reduced two-fold in activity in exponentially growing cells (compare Figure 6a and b; Exp). Furthermore, cells carrying only the wild-type fulllength 1.7 kbp promoter are repressed 2.5-fold when serum-depleted (Figure 6a ; 0 h). This reduction is not observed with the 1.7 kbp À972/À953 deletion construct (Figure 6b ; 0 h). Deletion of the À972/À953 site also altered promoter activity upon serum stimulation. In the controls carrying the wild-type full-length 1.7 kbp promoter, promoter activity begins to Figure 7 increase by 3 h post-serum stimulation (Figure 2c and 6a) , while the À972/À953 deletion resulted in no detectable changes in activity until 8 h postserum stimulation at which point expression is induced greater than sevenfold relative to the expression of the wild-type full-length promoter at 8 h (compare Figure 6a and b; 8 h) .
Sequestering trans-acting factors reduces p53 promoter activity in exponentially growing cells To further demonstrate that the factor(s) binding to the À972/À953 cis-acting element are required for both basal and cell cycle regulated promoter activity, we designed an experiment to sequester the trans-acting factors in order to prevent/reduce their binding to the p53 promoter. Exponentially growing Swiss3T3 cells were co-transfected with increasing amounts of the À972/À953 cis-acting element that was concatemerized (4 Â ) and cloned into the PUC19 vector along with the 1.7 kbp promoter to assay promoter activity. We reasoned that the introduction of multiple copies Sequestering trans-acting factor(s) alters cell cycle regulation of p53 promoter activity As described above, we demonstrated that the À972/ À953 site on the p53 promoter plays a role in cell cycle regulated promoter activity by deleting this site from the promoter. As another approach to demonstrate the importance of the factors binding within this region on the promoter, we assayed wild-type full-length 1.7 kbp promoter during the cell cycle in the presence of the construct used to sequester the binding factors. Serum-depleted and stimulated cells transfected with the 1.7 kbp promoter exhibit cell cycle regulated promoter activity (Figures 2c and 7b) , while cells cotransfected with the concatemerized sites exhibit a very different pattern of promoter activity compared to the 1.7 kbp promoter in the absence of the sequestration construct (Figure 7b and c) . Promoter activity, in response to mitogen treatment, in the presence of the concatemerized binding sites was virtually identical to that seen upon deletion of the binding site (compare Figure 6b and 7c) . In the presence of the concatemerized binding sites, promoter activity in exponentially growing cells is reduced three-fold in comparison to promoter activity in the absence of the sequestration construct (compare Figure  7b and c; Exp) . Similar to what was observed when the À972/À953 promoter deletion was tested, there was no further reduction occurring upon serum depletion (Figure 7c ; 0 h). Sequestering the binding factors also led to an alteration in the response of promoter activity upon serum stimulation. In the controls carrying only the wild-type full-length 1.7 kbp promoter, activity begins to increase by 3 h postserum stimulation (Figure 2c and 7b) , while the sequestration of the factors resulted in no detectable changes in promoter activity until 8 h poststimulation, at which point expression is induced threefold higher than the expression of the 1.7 kbp promoter at 8 h postserum stimulation (compare Figure 7b and c; 8 h) . These results, in combination with our results using the À972/ À953 deletion, indicate that the factors binding within the À972/À953 site on the p53 promoter are essential for proper modulation of p53 transcription as cells are arrested in G 0 /G 1 and contribute to an early phase of induced expression prior to S phase. Clearly, there must be numerous contributing regulatory factors involved in transcriptional regulation of p53 during the cell cycle since both deletion of the À972/À953 site and sequestration of the À972/À953 trans-acting factors result in a drastically altered pattern of gene expression and kinetics.
C/EBPb is a candidate transcription factor that participates in regulation of p53 transcription In order to begin to identify factors that may be binding to the À972/À953 region of the p53 promoter and regulating its expression, we used the Matlnspector At 18 h after transfection, the cells were maintained in serum-depleted medium for 24 h (0 h) and then serum stimulated. Cells were harvested 3, 8, 18 and 24 h postserum stimulation and tested for luciferase activity. The results were normalized to TKRenilla. (c) Exponentially growing Swiss3T3 cells were transfected with 0.75 mg of the 1.7 kbp promoter and 10 mg of the concatemerized sites in duplicate experiments. The transfected cells were treated and tested exactly the same as described above in (b).
Professional Database (www.genomatix.de/site_map/index.html) to search known transcription factor binding sites. Potential candidates were identified in this fashion. The consensus binding sites for two more well characterized of these factors, C/EBPb and Ikaros-2, are shown in Figure 8a . To test whether binding to the p53 À972/À953 element may be C/EBPb or Ikaros-2 we designed double-stranded oligonucleotide with random nucleotides surrounding the C/EBPb and Ikaros-2 consensus binding sites and used them as unlabeled specific competitors in EMSA (Figure 8b ). If either of these factors bind to this site on the p53 promoter, binding is predicted to be competed by the specific competitor (the À972/À953 region) as well as the oligonucleotide harboring the candidate consensus binding. As shown in Figure 8c , binding is efficiently competed by the C/EBPb site but not by the Ikaros-2 site. These results indicate that C/EBPb can potentially bind to the À972/À953 site on the p53 promoter and is thus a strong candidate for a factor that regulates p53 transcription.
Discussion
It has been known for some time that p53 mRNA levels are cell cycle regulated; in particular, transcription of p53 is known to be induced upon mitogen stimulation of resting cells, with peak levels of mRNA occurring prior to S phase and maximal levels of p53 protein occurring in mid S phase (Reich and Levine, 1984; Reed et al, 1986; Ginsberg et al, 1990; Mosner et al., 1995) . The kinetics of this response has been suggested to be important for a rapid p53-induced arrest in response to DNA damage during S phase, a time when cells are synthesizing DNA and most susceptible to DNAdamaging events (Mosner et al., 1995) . In fact, Mosner et al. (1995) demonstrated a rapid accumulation of active p53 protein in response to DNA damage in synchronized cells in mid-S phase. Increased synthesis of p53 during this phase of the cell cycle would be predicted to provide p53 protein poised to act and serve an a type of 'rapid response' system for preventing the replication of damaged DNA. Therefore, an understanding of the mechanism(s) responsible for regulating p53 transcription will provide additional insights into p53.
During different phases of the cell cycle, in response to mitogen treatment, we have shown differential binding of a trans-acting factor(s) within the À972/ À953 region of the p53 promoter. Binding was reduced after cells were serum-depleted for 24 h and increased at 3 h post-serum stimulation. This pattern of binding coincides with endogenous p53 mRNA expression levels in serum-treated Swiss3T3 cells. The factor(s) that is bound to the p53 promoter may be modified, as indicated by a shift in the mobility of the bound factor(s) at 3 h postserum stimulation.
The trans-acting factor or factors binding within the À972/À953 positive cis-acting element are necessary for maximal p53 promoter activity in exponentially growing cells. In their absence, due to sequestration, or when the À972/À953 site is deleted, p53 promoter activity is reduced and no further reduction occurs upon cell cycle arrest. At 3 h postserum stimulation, promoter activity fails to increase when the factors are sequestered as opposed to the response we have shown to occur when the factors are present. This indicates that these factors are necessary for maximal p53 promoter activity as well as to upregulate promoter activity as the cells begin to re-enter the cell cycle in G 1 . In contrast to what is observed in normal cells, promoter activity in cells that have the À972/À953 trans-acting factors sequestered or the À972/À953 element deleted exhibit a delay in increase in promoter activity. In this case, the increase in activity is observed at the G 1 /S boundary (8 h postserum stimulation) rather than upon re-entry into the cell cycle beginning in early G 1 (3 h postserum stimulation). In addition to a delay in promoter activity, both the deletion of the À972/À953 site on the p53 promoter and the sequestration of the factors binding within the À972/À953 site resulted in elevated expression (seven and three-fold, respectively) of the p53 promoter at 8 h postserum As with other genes, multiple factors are likely to be involved in the regulating expression of p53. This appears to be the case since, in addition to factors already known to bind the p53 promoter Wu and Lozano, 1994; Hale and Braithwaite, 1995; Lasham et al., 2003) , we have identified binding within three more regulatory regions in the 1000 bp upstream region. These regions may therefore contribute to the expression pattern observed in the absence of the À972/À953 site. Some of these elements appear to participate in negative regulation of the promoter and may also be involved in the cell cycle regulated expression.
Database searches for transcription factors that may bind the p53 promoter within the À972/À953 element have provided possible leads as to what protein(s) are binding the promoter within this critical element. One factor in particular, C/EBPb, appears to bind to this site on the promoter (Figure 8 ). C/EBPb is a CCAAT enhancer binding protein and is critical for normal growth and differentiation of epithelial cells in the mammary gland Sealy and Bundy, 2003) . C/EBPb has been shown to bind the serum response element within the c-fos promoter in response to mitogenic stimulation upon dependent on activation of the Rasdependent signaling pathway (Hanlon and Sealy, 1999) . Also, increased C/EBPb levels are found in many ovarian and breast cancers (Arnett et al., 2003; Milde-Langosch et al., 2003) . RBP-Jk is another potential candidate derived from the database search that still needs to be tested. This particular factor has been shown to bind the interleukin-6 (IL-6) promoter and regulate its expression (Plaisance et al., 1997; Miyazawa et al., 1998) . Interestingly, it was recently reported that binding by C/EBPb to a site overlapping the RBP-Jk binding site dictates whether RBP-Jk will activate or repress IL-6 expression (Vales and Friedl, 2002) .
To further evaluate the role of C/EBPb and other DNA-binding proteins in regulating p53 expression, their identification and further characterization will be crucial and is now in progress. Ultimately, experiments utilizing siRNA will be invaluable in elucidating the role that these factors play in regulation of p53 expression in both normal and transformed cells.
Materials and methods
Cell culture
Murine fibroblasts (Swiss3T3) were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS (Atlas Biologicals), 2 mM L-glutamine (GibcoBRL), 100 u/ml penicillin and 100 /ml streptomycin. Cells were cultured at 371C in a humidified atmosphere of 6% CO 2 .
DNA synthesis assay 3 Â l0 5 Swiss3T3 cells were maintained in DMEM with 10% FBS prior to serum depletion with DMEM containing 0.1%. FBS for 24 h. Cells were stimulated with DMEM containing 15% FBS and harvested at the indicated time-points postserum stimulation. For each harvest, the medium was removed and replaced with medium containing 5 mCi/ml [ 3 H]thymidine (70-90 Ci/mmol; Perkin-Elmer) for 30 min at 371C. Radioactive thymidine was removed by washing three times with phosphate-buffered saline (PBS) containing 5 mg/ml nonradioactive thymidine. Samples were pelleted, lysed with 0.1 N NaOH and precipitated onto 24 mm glass microfibre filter paper (Whatman) with trichloroacetic acid (TCA) and washed with ethanol.
[ 3 H]thymidine incorporation was assayed by measuring the amount of radioactivity by scintillation counting.
Northern blot analysis Total RNA, l0 mg, was loaded onto a 1% agarose gel containing formaldehyde. RNA was transferred to a nylon membrane (Biotrace NT, 0.45 mm; Gelman Sciences). Membrane was prehybridized at 421C (2:1 ratio of Ambion ULTRAhyb and 50% Formamide, 5 Â SSPE, 5 Â Denhardt's, 100 mg/ml denatured salmon sperm DNA and 0.1% SDS) and hybridized to cDNA labeled with 50 mCi [a-32 P]dATP (3000 Ci/ mmol; Perkin-Elmer) overnight at 421C. The membrane was washed with 1 Â SSPE/0.1% SDS (150 mM NaCl, l0 mM NaH 2 PO 4 Á H 2 O and 1 mM 0.5 M EDTA pH 8.0), 0.5 Â SSPE/ 0.1% SDS and 0.1 Â SSPE/0.1% SDS at 601C. Stripping of the membrane was performed with boiling 0.1 Â SSC (15 mM NaCl and 1.5 mM NaCitrate) and 0.1% SDS prior to reprobing. RNA levels were determined by subjecting membrane to autoradiography for 3 days. Equal RNA loading was confirmed by staining the gels with ethidium bromide and visualizing 18 and 28S rRNA.
Transfections and reporter gene assays The 0.7 kbp. contains the 672 bp murine promoter fragment cloned into the Hindlll site of the pGL3-basic luciferase vector (Promega). The 1.7 kbp contains a 1672 bp Kpnl-Hindlll fragment isolated from the murine genome and cloned into the Kpnl and Hindlll sites of the pGL3-basic luciferase vector (Reisman et al., 2001) . 5 Â 10 4 Swiss3T3 cells on 24-well plates were transfected (TransFast Transfection Reagent; Promega) with pGL3-basic luciferase reporter construct (Promega) and 50 ng of Renilla driven by the HSV-TK promoter (pRL-TK Vector; Promega) as an internal control. At 18 h after transfection, Swiss3T3 cells were grown in serum-depleted medium (0.1% FBS) for 24 h followed by serum stimulation (15% FBS). Cells were lysed at the indicated timepoints and assayed for luciferase activity (Promega) using equal amounts of protein as determined by Bradford assays. Reporter gene activity was normalized to TK-Renilla activity (Promega). Data are shown as means7standard errors.
PCR-directed deletions
To identify the regulatory binding sites on the 1.7 kbp. promoter fragment, PCR-directed deletion analysis was carried out using primers that map progressively to the 3 0 end of the promoter. PCR amplification, in which 120-170 bp were progressively deleted, was performed with the following primers: 1. Electrophoretic mobility shift assay Plates of cells were washed twice with ice-cold PBS and lysed on ice with a hypotonic lysis buffer (20 mM HEPES pH 7.6,. 10 mM NaCl, 1.5 mM MgCl 2 , 0.2mM EDTA, 20% glycerol, 0.1% Triton X-100, 1 mM DTT, 1 mM PMSF, l mg/ml pepstatin and l mg/ml aprotinin). Nuclei were resuspended at 2.5 Â 10 7 nuclei per ml in nuclear extraction buffer (identical to lysis buffer except with 500 mM NaCl), gently rocked for 1 h at 41C, centrifuged at 10 000 rev/min for 10 min and supernatant stored at À701C.
The binding reaction consisted of 10 fmol/reaction [g-32 P]ATP end-labeled double-stranded oligonucleotide, 2 mg poly (dIÀdC) in binding buffer TM.1 (50 mM Tris-HCl pH 7.9, 0.1 M KC1,12.5 mM MgCl 2 , 10 mM EDTA, 20% glycerol and 1 mM DTT) and incubated on ice 15 min followed by room temperature incubation for 15 min. The products were separated on a 4% polyacrylamide gel at 41C in 0.5 Â TBE (0.045 M Tris-borate, 1 mM EDTA). Gels were dried and subjected to autoradiography for 30 min to 6 h. To test for specificity, EMSA was performed with unlabeled specific and non-specific competitors ranging from 10 to 50-fold molar excess of the labeled probe. Double-stranded 20-30 bp regions with two or three base pair changes, purine to a noncomplimentary pyrimidine or vice versa, within each binding site were used to probe nuclear extracts from Swiss3T3.
In vitro site directed mutagenesis The À972/À953 cis-acting element within the 1.7 kbp. pGL3-basic luciferase reporter construct was deleted using GeneEditor in vitro site-directed mutagenesis system kit (Promega). The following mutant sense oligonucleotide was 5 0 -phosphorylated and used to delete the site: 5 0 -CAAGTTCTTACTGCCT AACCCAGGACTATACAAGGCAAAATAGCAATGTTTT CTAG-3 0 .
